Total Assets Summary of Shilpa Medicare Limited

Shilpa Medicare Limited's latest annual total assets in 2023 was 30.93 Billion INR , up 6.57% from previous year.
Shilpa Medicare Limited's latest quarterly total assets in 2024 Q1 was - INR , down -100.0% from previous quarter.
Shilpa Medicare Limited reported annual total assets of 29.02 Billion INR in 2022, up 0.93% from previous year.
Shilpa Medicare Limited reported annual total assets of 28.75 Billion INR in 2021, up 9.02% from previous year.
Shilpa Medicare Limited reported quarterly total assets of - INR for 2023 Q1, down -100.0% from previous quarter.
Shilpa Medicare Limited reported quarterly total assets of 30.93 Billion INR for 2023 Q4, down 0.0% from previous quarter.

Annual Total Assets Chart of Shilpa Medicare Limited (2023 - 2007)

Historical Annual Total Assets of Shilpa Medicare Limited (2023 - 2007)

Year	Total Assets	Total Assets Growth
2023	30.93 Billion INR	6.57%
2022	29.02 Billion INR	0.93%
2021	28.75 Billion INR	9.02%
2020	26.37 Billion INR	32.8%
2019	19.86 Billion INR	23.35%
2018	16.1 Billion INR	5.13%
2017	15.31 Billion INR	11.32%
2016	13.75 Billion INR	29.56%
2015	10.61 Billion INR	17.4%
2014	9.04 Billion INR	33.45%
2013	6.77 Billion INR	22.92%
2012	5.51 Billion INR	27.4%
2011	4.32 Billion INR	24.88%
2010	3.46 Billion INR	32.9%
2009	2.6 Billion INR	18.25%
2008	2.2 Billion INR	22.19%
2007	1.8 Billion INR	0.0%

Year	Total Assets	Total Assets Growth
2024 Q1	- INR	-100.0%
2023 Q1	- INR	-100.0%
2023 Q4	30.93 Billion INR	0.0%
2023 Q3	- INR	-100.0%
2023 FY	30.93 Billion INR	6.57%
2023 Q2	30.04 Billion INR	0.0%
2022 Q1	- INR	-100.0%
2022 FY	29.02 Billion INR	0.93%
2022 Q4	29.02 Billion INR	0.0%
2022 Q3	- INR	-100.0%
2022 Q2	29.82 Billion INR	0.0%
2021 FY	28.75 Billion INR	9.02%
2021 Q1	- INR	-100.0%
2021 Q4	28.75 Billion INR	0.0%
2021 Q3	- INR	-100.0%
2021 Q2	26.98 Billion INR	0.0%
2020 Q1	- INR	-100.0%
2020 FY	26.37 Billion INR	32.8%
2020 Q3	- INR	-100.0%
2020 Q4	26.37 Billion INR	0.0%
2020 Q2	24.86 Billion INR	0.0%
2019 FY	19.86 Billion INR	23.35%
2019 Q2	17.9 Billion INR	0.0%
2019 Q3	- INR	-100.0%
2019 Q4	19.86 Billion INR	0.0%
2019 Q1	- INR	-100.0%
2018 Q4	16.1 Billion INR	0.0%
2018 Q3	- INR	-100.0%
2018 Q2	15.1 Billion INR	0.0%
2018 FY	16.1 Billion INR	5.13%
2018 Q1	- INR	-100.0%
2017 Q1	- INR	-100.0%
2017 Q3	- INR	-100.0%
2017 FY	15.31 Billion INR	11.32%
2017 Q4	15.31 Billion INR	0.0%
2017 Q2	14.65 Billion INR	0.0%
2016 Q2	10.59 Billion INR	0.0%
2016 Q4	13.75 Billion INR	0.0%
2016 Q3	- INR	-100.0%
2016 FY	13.75 Billion INR	29.56%
2015 Q4	10.61 Billion INR	0.0%
2015 Q2	10.06 Billion INR	0.0%
2015 Q1	- INR	-100.0%
2015 Q3	- INR	-100.0%
2015 FY	10.61 Billion INR	17.4%
2014 Q4	9.04 Billion INR	0.0%
2014 FY	9.04 Billion INR	33.45%
2014 Q3	- INR	-100.0%
2014 Q2	8.42 Billion INR	0.0%
2014 Q1	- INR	-100.0%
2013 FY	6.77 Billion INR	22.92%
2013 Q2	6.11 Billion INR	0.0%
2013 Q3	- INR	-100.0%
2013 Q4	6.77 Billion INR	0.0%
2013 Q1	- INR	-100.0%
2012 Q3	- INR	-100.0%
2012 FY	5.51 Billion INR	27.4%
2012 Q4	5.51 Billion INR	0.0%
2012 Q2	5 Billion INR	0.0%
2011 FY	4.32 Billion INR	24.88%
2011 Q4	4.32 Billion INR	0.0%
2010 FY	3.46 Billion INR	32.9%
2009 FY	2.6 Billion INR	18.25%
2008 FY	2.2 Billion INR	22.19%
2007 FY	1.8 Billion INR	0.0%

Peer Total Assets Comparison of Shilpa Medicare Limited

Name	Total Assets	Total Assets Difference
Sigachi Industries Limited	6.94 Billion INR	-345.606%
Ind-Swift Limited	6.54 Billion INR	-372.626%
Bajaj HealthCare Limited	7.65 Billion INR	-304.273%
Sakar Healthcare Limited	3.88 Billion INR	-695.866%
Aurobindo Pharma Limited	450.71 Billion INR	93.137%
Innova Captab Limited	13.2 Billion INR	-134.177%
Divi's Laboratories Limited	154.7 Billion INR	80.005%
AstraZeneca Pharma India Limited	10.78 Billion INR	-186.932%
Morepen Laboratories Limited	12.93 Billion INR	-139.189%
Mankind Pharma Limited	119.63 Billion INR	74.144%
Sequent Scientific Limited	15.4 Billion INR	-100.807%
Wanbury Limited	3.43 Billion INR	-800.514%
Laurus Labs Limited	83.87 Billion INR	63.119%
Nectar Lifesciences Limited	21.91 Billion INR	-41.174%
Glenmark Life Sciences Limited	28.5 Billion INR	-8.518%
Alembic Limited	23.28 Billion INR	-32.826%
Hikal Limited	24.87 Billion INR	-24.368%
Alembic Pharmaceuticals Limited	64.45 Billion INR	52.01%
Neuland Laboratories Limited	18.32 Billion INR	-68.791%
J. B. Chemicals & Pharmaceuticals Limited	39.94 Billion INR	22.556%
Glenmark Pharmaceuticals Limited	143.58 Billion INR	78.458%
IOL Chemicals and Pharmaceuticals Limited	22.44 Billion INR	-37.819%
Themis Medicare Limited	5.66 Billion INR	-446.101%
RPG Life Sciences Limited	5.12 Billion INR	-503.117%
Zydus Lifesciences Limited	292.8 Billion INR	89.436%
Lupin Limited	239.97 Billion INR	87.11%
Amrutanjan Health Care Limited	3.66 Billion INR	-743.132%
Wockhardt Limited	76.49 Billion INR	59.561%
Vaishali Pharma Limited	799.55 Million INR	-3768.648%
Aarti Pharmalabs Limited	25.82 Billion INR	-19.794%
Jagsonpal Pharmaceuticals Limited	2.17 Billion INR	-1324.928%
Jubilant Pharmova Limited	115.48 Billion INR	73.216%
FDC Limited	24.68 Billion INR	-25.328%
Dr. Reddy's Laboratories Limited	387.51 Billion INR	92.018%
Kilitch Drugs (India) Limited	2.4 Billion INR	-1188.504%
Eris Lifesciences Limited	70.48 Billion INR	56.118%
Venus Remedies Limited	6.26 Billion INR	-393.468%
ZIM Laboratories Limited	4.46 Billion INR	-592.267%
Bliss GVS Pharma Limited	12.13 Billion INR	-154.822%
Par Drugs and Chemicals Limited	1.01 Billion INR	-2944.16%
Caplin Point Laboratories Limited	26.97 Billion INR	-14.674%
Albert David Limited	4.97 Billion INR	-521.136%
Ajanta Pharma Limited	46.38 Billion INR	33.313%
Hester Biosciences Limited	6.62 Billion INR	-367.007%
Suven Pharmaceuticals Limited	22.54 Billion INR	-37.227%
Solara Active Pharma Sciences Limited	23.46 Billion INR	-31.816%
Gufic Biosciences Limited	10.92 Billion INR	-183.12%
Windlas Biotech Limited	6.26 Billion INR	-393.96%
Procter & Gamble Health Limited	7.94 Billion INR	-289.396%
Aarey Drugs & Pharmaceuticals Limited	3.04 Billion INR	-914.192%
Mangalam Drugs & Organics Limited	3.33 Billion INR	-827.708%
Granules India Limited	55.2 Billion INR	43.974%
Aarti Drugs Limited	24.32 Billion INR	-27.169%
Bal Pharma Limited	3.2 Billion INR	-865.453%
Alkem Laboratories Limited	155.74 Billion INR	80.14%
Sun Pharmaceutical Industries Limited	854.62 Billion INR	96.381%
Lincoln Pharmaceuticals Limited	7 Billion INR	-341.703%
Medicamen Biotech Limited	2.94 Billion INR	-950.244%
Unichem Laboratories Limited	31.69 Billion INR	2.402%
Bafna Pharmaceuticals Limited	1.47 Billion INR	-1994.509%
Biofil Chemicals and Pharmaceuticals Limited	470.82 Million INR	-6469.726%
Valiant Laboratories Limited	3.42 Billion INR	-802.632%
Orchid Pharma Limited	15.53 Billion INR	-99.064%
Medico Remedies Limited	961.95 Million INR	-3115.546%
Ind-Swift Laboratories Limited	11.65 Billion INR	-165.487%
Ipca Laboratories Limited	111.01 Billion INR	72.137%
Brooks Laboratories Limited	904.45 Million INR	-3319.969%
Syncom Formulations (India) Limited	4.04 Billion INR	-664.389%
Piramal Enterprises Limited	826.05 Billion INR	96.255%
Torrent Pharmaceuticals Limited	150.61 Billion INR	79.462%
NATCO Pharma Limited	69.06 Billion INR	55.212%
Suven Life Sciences Limited	2.84 Billion INR	-985.706%
Krebs Biochemicals & Industries Limited	1.78 Billion INR	-1636.051%
Strides Pharma Science Limited	58.39 Billion INR	47.032%
Indoco Remedies Limited	21.44 Billion INR	-44.223%
Alpa Laboratories Limited	1.82 Billion INR	-1593.777%
Lasa Supergenerics Limited	1.5 Billion INR	-1950.263%
Sun Pharma Advanced Research Company Limited	5.15 Billion INR	-500.576%

Global Stocks Search

Shilpa Medicare Limited (SHILPAMED.NS)

Total Assets Summary of Shilpa Medicare Limited

Annual Total Assets Chart of Shilpa Medicare Limited (2023 - 2007)

Historical Annual Total Assets of Shilpa Medicare Limited (2023 - 2007)

Peer Total Assets Comparison of Shilpa Medicare Limited